Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
News headlines Recursion Pharmaceuticals reported mixed Q2 2026 results, showing a $7.67 million revenue decline from last year. The company announced significant clinical advancements and strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results